Kimberly Gentile

Kimberly Gentile

Senior Vice President, Clinical OperationsatBiohaven· In proxies 2023–2025

Pay in FY2025+3% from the year before

Kimberly Gentile was paid $4.0M in FY2025 (Dec), up 3%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Biohaven proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. BiohavenPublic company · 3 yr
    • Senior Vice President, Clinical Operations2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?